News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
41,644 Results
Type
Article (2761)
Company Profile (43)
Press Release (38840)
Multimedia
Podcasts (17)
Webinars (2)
Section
Business (14325)
Career Advice (78)
Deals (2145)
Drug Delivery (10)
Drug Development (4348)
Employer Resources (10)
FDA (486)
Job Trends (806)
News (20709)
Policy (1148)
Tag
Academia (147)
ADA (4)
Adcomms (1)
Allergies (7)
Alliances (3500)
ALS (6)
Alzheimer's disease (67)
Antibody-drug conjugate (ADC) (48)
Approvals (483)
Artificial intelligence (44)
ASCO (16)
Autoimmune disease (26)
Automation (4)
Bankruptcy (12)
Best Places to Work (495)
BIOSECURE Act (2)
Biosimilars (24)
Biotechnology (29)
Bladder cancer (10)
Brain cancer (8)
Breast cancer (54)
Cancer (420)
Cardiovascular disease (14)
Career advice (67)
Career pathing (1)
CAR-T (43)
CDC (24)
Cell therapy (104)
Cervical cancer (5)
Clinical research (3738)
Collaboration (256)
Company closure (3)
Compensation (134)
COVID-19 (208)
CRISPR (12)
C-suite (166)
Cystic fibrosis (8)
Data (592)
Denatured (6)
Depression (12)
Dermatology (1)
Diabetes (30)
Diagnostics (507)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (48)
Drug pricing (10)
Duchenne muscular dystrophy (60)
Earnings (4733)
Editorial (14)
Employer branding (1)
Employer resources (8)
Events (6710)
Executive appointments (149)
FDA (679)
Friedreich's ataxia (7)
Frontotemporal dementia (1)
Funding (223)
Gene editing (39)
Generative AI (3)
Gene therapy (76)
GLP-1 (80)
Government (221)
Guidances (24)
Healthcare (737)
Hematology (8)
HIV (3)
Huntington's disease (6)
IgA nephropathy (16)
Immunology and inflammation (40)
Immuno-oncology (18)
Indications (11)
Infectious disease (237)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (12)
Intellectual property (39)
Interviews (7)
IPO (1019)
IRA (7)
Job creations (296)
Job search strategy (62)
JPM (7)
Kidney cancer (8)
Labor market (13)
Layoffs (56)
Leadership (4)
Legal (219)
Liver cancer (6)
Longevity (6)
Lung cancer (39)
Lymphoma (14)
Machine learning (3)
Management (4)
Manufacturing (77)
MASH (19)
Medical device (317)
Medtech (322)
Mergers & acquisitions (1267)
Metabolic disorders (111)
mRNA (19)
Multiple sclerosis (26)
Neurodegenerative disease (39)
Neuropsychiatric disorders (11)
Neuroscience (197)
NextGen: Class of 2026 (356)
Non-profit (158)
Now hiring (15)
Obesity (52)
Opinion (21)
Ovarian cancer (26)
Pain (33)
Pancreatic cancer (27)
Parkinson's disease (16)
Partnered (4)
Patents (71)
Patient recruitment (54)
Peanut (1)
People (6036)
Pharmaceutical (3)
Phase 1 (1594)
Phase 2 (1843)
Phase 3 (992)
Pipeline (747)
Policy (52)
Postmarket research (33)
Preclinical (673)
Press Release (2)
Prostate cancer (8)
Psychedelics (4)
Radiopharmaceuticals (18)
Rare diseases (91)
Real estate (425)
Recruiting (5)
Regulatory (1032)
Reports (8)
Research institute (151)
Resumes & cover letters (9)
Rett syndrome (3)
RNA editing (5)
RSV (4)
Schizophrenia (17)
Series A (57)
Series B (25)
Service/supplier (2)
Sickle cell disease (3)
Special edition (4)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (503)
Stomach cancer (3)
Supply chain (7)
Tariffs (3)
The Weekly (10)
Vaccines (121)
Venture capital (17)
Weight loss (29)
Women's health (19)
Worklife (1)
Date
Today (4)
Last 7 days (44)
Last 30 days (227)
Last 365 days (2463)
2026 (1218)
2025 (2528)
2024 (2653)
2023 (2903)
2022 (3784)
2021 (4083)
2020 (3517)
2019 (2126)
2018 (1607)
2017 (1813)
2016 (1637)
2015 (1860)
2014 (1386)
2013 (1197)
2012 (1401)
2011 (1341)
2010 (1193)
Location
Africa (46)
Alabama (3)
Arizona (20)
Asia (2018)
Australia (312)
California (1990)
Canada (311)
China (108)
Colorado (72)
Connecticut (18)
Delaware (10)
Europe (4152)
Florida (73)
Georgia (20)
Hawaii (2)
Idaho (3)
Illinois (28)
India (3)
Indiana (74)
Japan (21)
Kansas (15)
Kentucky (1)
Louisiana (2)
Maryland (71)
Massachusetts (742)
Michigan (15)
Minnesota (28)
Mississippi (1)
Missouri (6)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (169)
New York (104)
North Carolina (158)
Northern California (1016)
Ohio (58)
Oklahoma (2)
Oregon (7)
Pennsylvania (141)
Puerto Rico (1)
Rhode Island (3)
South America (40)
South Carolina (2)
Southern California (803)
Tennessee (5)
Texas (187)
United States (4030)
Utah (7)
Virginia (14)
Washington D.C. (4)
Washington State (112)
West Virginia (1)
Wisconsin (17)
41,644 Results for "antiva biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Antiva Biosciences Presents Data from Phase 1b/2 Study of ABI-2280 for Treatment of Cervical High-Risk HPV Infection at SGO 2026
April 15, 2026
·
6 min read
Biotech Bay
Antiva Biosciences Announces Formation of Scientific and Development Advisory Board
Antiva Biosciences announced the formation of a scientific and development advisory board featuring distinguished thought leaders from both academia and industry with clinical expertise spanning the fields of women’s health and virology.
June 13, 2024
·
7 min read
Business
Antiva Biosciences Strengthens Leadership with Key New Appointments
Antiva Biosciences today announced several key new appointments designed to strengthen the company’s leadership as it continues to advance its lead development candidate, ABI-2280.
October 19, 2023
·
6 min read
Biotech Bay
Antiva Biosciences Closes $53 Million Series E Equity Financing Led by MPM-BioImpact Capital and Names Kristine Ball President and CEO
Antiva Biosciences today announced the closing of a $53 million Series E equity financing.
April 27, 2023
·
6 min read
Press Releases
Solid Biosciences to Participate at Upcoming June 2026 Investor Conferences
June 1, 2026
·
1 min read
Press Releases
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia
May 24, 2026
·
5 min read
Press Releases
Protillion Biosciences Announces Drug Discovery Collaboration with Merck
June 16, 2026
·
2 min read
Press Releases
Genflow Biosciences PLC Announces Notice of AGM
June 4, 2026
·
2 min read
Press Releases
Enveric Biosciences Announces Participation in 2026 BIO International Convention
June 16, 2026
·
3 min read
Biotech Bay
Antiva Biosciences Closes $31 Million Series D Equity Financing
Antiva Biosciences today announced the closing of a $31 million Series D equity financing.
November 2, 2021
·
5 min read
1 of 4,165
Next
